Biote (BTMD) Preferred Stock Liabilities (2021 - 2022)
Biote's quarterly Preferred Stock Liabilities came in at $317.5 million in Q1 2022, little changed year-on-year from $317.5 million in Q1 2021, and little changed quarter-over-quarter from $317.5 million in Q4 2021.
Biote has reported Preferred Stock Liabilities for 2 years, with the latest figure at $317.5 million in Q1 2022.
- For the quarter ending Q1 2022, Preferred Stock Liabilities changed 0.0% year-over-year to $317.5 million; the trailing twelve-month figure through Mar 2022 stood at $317.5 million (changed 0.0% YoY), and the FY2021 full-year result was $317.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2022 stood at $317.5 million, roughly flat from $317.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $317.5 million in Q2 2021, with the low at $317.5 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | - |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | - |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | - |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | Biote | 61.29 Mn | 64.11 Mn | 30.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 317.50 Mn |
| Dec 31, 2021 | 317.50 Mn |
| Sep 30, 2021 | 317.50 Mn |
| Jun 30, 2021 | 317.50 Mn |
| Mar 31, 2021 | 317.50 Mn |